something on the horizon?, page-23

ahpigsy, I don't see the link personally. OBJs short-term focus is on completely different set of applications to POHs. Both have great potential. The only thing I will say is I don't see any real potential for OBJ in the pain control area, especially snce they have announced they want to go it alone. POH have been working on this type of patch for years and even now it's still a year or more away from completing Phase III trials for FDA approval considerations. It's a long road.